Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Background: Patients unsuccessfully treated by neurostimulation may represent a highly intractable subgroup of depression. While the efficacy of intravenous (IV) ketamine has been established in patients with treatment-resistant depression (TRD), there is an interest to evaluate its effectiveness in a subpopulation with a history of neurostimulation. Methods: This retrospective, posthoc analysis compared the effects of four infusions of IV ketamine in 135 (x̄ = 44 ± 15.4 years of age) neurostimulation-naïve patients to 103 (x̄ = 47 ± 13.9 years of age) patients with a history of neurostimulation. The primary outcome evaluated changes in depression severity, measured by the Quick Inventory for Depression Symptomatology-Self Report 16-Item (QIDS-SR 16). Secondary outcomes evaluated suicidal ideation (SI), anxiety severity, measured by the Generalized Anxiety Disorder 7-Item (GAD-7), and consummatory anhedonia, measured by the Snaith–Hamilton Pleasure Scale (SHAPS). Results: Following four infusions, both cohorts reported a significant reduction in QIDS-SR 16 Total Score (F (4, 648) = 73.4, P < .001), SI (F (4, 642) = 28.6, P < .001), GAD-7 (F (2, 265) = 53.8, P < .001), and SHAPS (F (2, 302) = 45.9, P < .001). No between-group differences emerged. Overall, the neurostimulation-naïve group had a mean reduction in QIDS-SR 16 Total Score of 6.4 (standard deviation [SD] = 5.3), whereas the history of neurostimulation patients reported a 4.3 (SD = 5.3) point reduction. Conclusion: IV ketamine was effective in reducing symptoms of depression, SI, anxiety, and anhedonia in both cohorts in this large, well-characterized community-based sample of adults with TRD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preliminary evidence indicates that the effectiveness of IV ketamine in individuals with TRD and history of non- response to neurostimulation (i.e., ECT or rTMS) is not reduced as compared to individuals with TRD and no prior neurostimulation treatment 204 .”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [204]
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384 · cited 2×
“Data were collected at point-of-care from patients using a tablet device and stored directly onto Research Electronic Data Capture.(22,23) Data were analyzed using Statistical Product and Service Solutions (SPSS version 23 for Mac; SPSS, Inc.”
MethodInfluentialA Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765
The REDCap consortium: building an international community of software platform partners
Harris, P. A., Taylor, R., Minor, B. L., Elliott, V., Fernandez, M., O'Neal, L., McLeod, L., Delacqua, G., Delacqua, F., Kirby, J., et al. (2019) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2019.103208 · Cited by 24,013
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · cited 3×
“outcomes.(2,7,8) Moreover, without maintenance treatment, relapses approximate 50%, even following successful ECT treatment.”
BackgroundRush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
Resting-state connectivity biomarkers define neurophysiological subtypes of depression
Drysdale, A. T., Grosenick, L., Downar, J., Dunlop, K., Mansouri, F., Meng, Y., Fetcho, R. N., Zebley, B., Oathes, D. J., Etkin, A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4246 · Cited by 2,170 · cited 1×
“Notably, it has been demonstrated that depression can be subdivided into neurophysiological subtypes based on distinct patterns of functional magnetic resonance imaging brain activity, and some biotypes show widely differential responses to rTMS.(30) Future clinical research may investigate patient response to neurost…”
BackgroundA scale for the assessment of hedonic tone the Snaith-Hamilton pleasure scale
Snaith, R. P., Hamilton, M., Morley, S., Humayan, A., Hargreaves, D., & Trigwell, P. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.167.1.99 · Cited by 1,778
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., Friedman, E. S., Bowden, C. L., Fossey, M. D., Ostacher, M. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064135 · Cited by 937 · cited 2×
“Evenhigher rates of TRDare observed inBD, as indicated by the Systematic Treatment Enhancement Program for Bipolar Disorder Study.(3) As such, low remission rates and inadequate response to current treatment options are a major unmet need within mood disorder populations.”
(1997) · PubMed · Cited by 727
Wilkinson, S. T., Ballard, E. D., Bloch, M. H., Mathew, S. J., Murrough, J. W., Feder, A., Sos, P., Wang, G., Zarate, C. A., & Sanacora, G. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17040472 · Cited by 696
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
aan het Rot, M., Collins, K. A., Murrough, J. W., Perez, A. M., Reich, D. L., Charney, D. S., & Mathew, S. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.038 · Cited by 690
Milev, R. V., Giacobbe, P., Kennedy, S. H., Blumberger, D. M., Daskalakis, Z. J., Downar, J., Modirrousta, M., Patry, S., Vila-Rodriguez, F., Lam, R. W., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716660033 · Cited by 586
Parikh, S. V., Quilty, L. C., Ravitz, P., Rosenbluth, M., Pavlova, B., Grigoriadis, S., Velyvis, V., Kennedy, S. H., Lam, R. W., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659418 · Cited by 562
Phillips, J. L., Norris, S., Talbot, J., Birmingham, M., Hatchard, T., Ortiz, A., Owoeye, O., Batten, L. A., & Blier, P. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18070834 · Cited by 418
The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Trial: A Review
Sinyor, M., Schaffer, A., & Levitt, A. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500303 · Cited by 396 · cited 1×
“The SequencedTreatmentAlternatives toRelieveDepression Studydemonstrated that only 60%of patients with MDD experienced full remission of symptoms, despite multiple intervention attempts.(1,2) Evenhigher rates of TRDare observed inBD, as indicated by the Systematic Treatment Enhancement Program for Bipolar Disorder Stu…”
BackgroundRelief of Expressed Suicidal Intent by ECT: A Consortium for Research in ECT Study
Kellner, C. H., Fink, M., Knapp, R., Petrides, G., Husain, M., Rummans, T., Mueller, M., Bernstein, H., Rasmussen, K., O’Connor, K., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.5.977 · Cited by 345 · cited 2×
“It is estimated that response rates for ECT are between 70% and 80%.(4,6) Converging lines of evidence suggest that a higher degree of treatment resistance is often predictive of poor treatment CNS Spectrums”
BackgroundResultThe use of ketamine as an antidepressant: a systematic review and meta‐analysis
Coyle, C. M., & Laws, K. R. (2015) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2475 · Cited by 279
Ibrahim, L., Diazgranados, N., Luckenbaugh, D. A., Machado-Vieira, R., Baumann, J., Mallinger, A. G., & Zarate, C. A. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.019 · Cited by 192 · cited 2×
“These findings comport and extend initial reports that a moderate effect size in depressive symptom reduction was associated with ECT-resistant patients (n = 17) who received a single infusion of IV ketamine.(17) In addition, following four infusions, approximately 20% of patients with a history of neurostimulation re…”
BackgroundResultEvans, J. W., Szczepanik, J., Brutsché, N., Park, L. T., Nugent, A. C., & Zarate, C. A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.027 · Cited by 173 · cited 1×
“Growing evidence suggests that ketamine’s antidepressant effects may be mediated through similar neural structures and functional networks targeted by neurostimulation modalities in refractory depression.(25,26) Similarly, proton magnetic resonance spectroscopy in murine models suggests that ECT may elevate Gamma amin…”
BackgroundSehatzadeh, S., Tu, H., Palimaka, S., Yap, B., O’Reilly, D. J., & Bowen, J. M. (2016) · PubMed Central · Cited by 155
Clinical Predictors of Acute Response With Quetiapine in Psychotic Mood Disorders
Zarate, C. A., Rothschild, A., Fletcher, K. E., Madrid, A., & Zapatel, J. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0307 · Cited by 124 · cited 2×
“outcomes.(2,7,8) Moreover, without maintenance treatment, relapses approximate 50%, even following successful ECT treatment.”
BackgroundRelapse of Depression After ECT: A Review
Bourgon, L. N., & Kellner, C. H. (2000) · The Journal of ECT · doi:10.1097/00124509-200003000-00003 · Cited by 118 · cited 1×
“Moreover, without maintenance treatment, relapses approximate 50%, even following successful ECT treatment.(9) Therefore, patients unsuccessfully treated with ECT treatments are left to try experimental neuromodulatory treatments such as deep brain stimulation or focused ultrasound, which requires further trials to ch…”
BackgroundCusin, C., Ionescu, D. F., Pavone, K. J., Akeju, O., Cassano, P., Taylor, N., Eikermann, M., Durham, K., Swee, M. B., Chang, T., et al. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416631828 · Cited by 111 · cited 1×
“75mg/kg, based on previous research suggesting that some patients require a higher dose of ketamine for full effects.(18) Eligibility for the dose increase was also based on patient preference and tolerance to the index dose.”
MethodMcIntyre, R. S., Rodrigues, N. B., Lee, Y., Lipsitz, O., Subramaniapillai, M., Gill, H., Nasri, F., Majeed, A., Lui, L. M. W., Senyk, O., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.088 · Cited by 110 · cited 1×
“The treatment protocol and eligibility criteria have previously been characterized in detail.(14) Only measures pertinent to this study will be described herein.”
MethodSelf-citationKetamine normalizes subgenual cingulate cortex hyper-activity in depression
Morris, L. S., Costi, S., Tan, A., Stern, E. R., Charney, D. S., & Murrough, J. W. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0591-5 · Cited by 104 · cited 1×
“Growing evidence suggests that ketamine’s antidepressant effects may be mediated through similar neural structures and functional networks targeted by neurostimulation modalities in refractory depression.(25,26) Similarly, proton magnetic resonance spectroscopy in murine models suggests that ECT may elevate Gamma amin…”
BackgroundCurrent and emerging brain applications of MR-guided focused ultrasound
Meng, Y., Suppiah, S., Mithani, K., Solomon, B., Schwartz, M. L., & Lipsman, N. (2017) · Journal of Therapeutic Ultrasound · doi:10.1186/s40349-017-0105-z · Cited by 66 · cited 6×
“Therefore, patients unsuccessfully treated with ECT treatments are left to try experimental neuromodulatory treatments such as deep brain stimulation or focused ultrasound, which requires further trials to characterize their effect on TRD.(10,11) Indeed, effective treatments for ECT-refractory depression are limited w…”
BackgroundInfluentialLi, D.-J., Wang, F.-C., Chu, C.-S., Chen, T.-Y., Tang, C.-H., Yang, W.-C., Chow, P. C.-K., Wu, C.-K., Tseng, P.-T., & Lin, P.-Y. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.11.008 · Cited by 51 · cited 2×
“Indeed, a meta-analysis of 346 patients receiving ketamine-ECT treatment demonstrated moderate antidepressant effects.(28) However, the cardiovascular side effect profile was significantly worse compared to controls.”
BackgroundRodrigues, N. B., Mithani, K., Meng, Y., Lipsman, N., & Hamani, C. (2018) · Brain Sciences · doi:10.3390/brainsci8020023 · Cited by 43 · cited 6×
“Therefore, patients unsuccessfully treated with ECT treatments are left to try experimental neuromodulatory treatments such as deep brain stimulation or focused ultrasound, which requires further trials to characterize their effect on TRD.(10,11) Indeed, effective treatments for ECT-refractory depression are limited w…”
BackgroundInfluentialSelf-citationBiedermann, S. V., Weber‐Fahr, W., Zheng, L., Hoyer, C., Vollmayr, B., Gass, P., Ende, G., & Sartorius, A. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.580778 · Cited by 37 · cited 1×
“Similarly, proton magnetic resonance spectroscopy in murine models suggests that ECT may elevate Gamma aminobutyric acid (GABA) and glutamate concentration.(27) To this end, there has been significant interest in combination therapy of ECT and ketamine as a viable treatment in TRD.”
BackgroundPhillips, J. L., Jaworska, N., Kamler, E., Bhat, V., Blier, J., Foster, J. A., Hassel, S., Ho, K., McMurray, L., Milev, R., et al. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02672-3 · Cited by 22 · cited 1×
“Novel research paradigms will look to investigate whether nonresponders to ECT or ketamine can cross-over into the other modality for treatment.(29) Notably, it has been demonstrated that depression can be subdivided into neurophysiological subtypes based on distinct patterns of functional magnetic resonance imaging b…”
BackgroundLu, B. Y., Agapoff, J. R., Olson, D., Tawata, W., Williams, S. R., Ona, C., & Carlton, B. (2020) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.19l02535 · Cited by 1 · cited 1×
“These results comport with Lu et al,(24) who reported that patients unable to receive ECT treatment due to medical risk may benefit from ketamine as a safe and effective treatment alternative.(24) Growing evidence suggests that ketamine’s antidepressant effects may be mediated through similar neural structures and fun…”
Result
Cited by
McIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., et al. (2023) · World Psychiatry · doi:10.1002/wps.21120 · Cited by 836
Self-citationMcIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., Sanacora, G., Murrough, J. W., Berk, M., Brietzke, E., Dodd, S., Gorwood, P., Ho, R., et al. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20081251 · Cited by 731
Self-citationPettorruso, M., Guidotti, R., d’Andrea, G., Risio, L. D., D’Andrea, A., Chiappini, S., Carullo, R., Barlati, S., Zanardi, R., Rosso, G., et al. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115378 · Cited by 65
Self-citationVan Amsterdam, J., & Van Den Brink, W. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1949454 · Cited by 44
“Ketamine has been extensively clinically used since the 1970s to effectively provide anesthesia and pain relief [68,69], and is generally known as a relatively safe therapeutic drug [70].”
BackgroundKetamine treatment for anhedonia in unipolar and bipolar depression: a systematic review
Kwaśny, A., Kwaśna, J., Wilkowska, A., Szarmach, J., Słupski, J., Włodarczyk, A., & Cubała, W. J. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.04.014 · Cited by 30
Metadata
- Authors
- Rodrigues, N. B., Siegel, A., Lipsitz, O., Cha, D. S., Gill, H., Nasri, F., Simonson, K., Shekotikhina, M., Lee, Y., Subramaniapillai, M., Kratiuk, K., Lin, K., Ho, R., Mansur, R. B., McIntyre, R. S., & Rosenblat, J. D.
- Affiliations
- University Health Network (CA)
- University of California, Riverside (US)
- University of Ottawa (CA)
- Guangzhou Medical University (CN)
- National University of Singapore (SG)
- Corresponding author
- McIntyre, Roger S.
- ORCID
- Venue
- CNS Spectrums
- Publisher
- Cambridge University Press (CUP)
- Published
- 2020-12-10
- Volume
- 27
- Issue
- 3
- Pages
- 315-321
- ISSN
- 1092-8529 (ISSN-L)
- 2165-6509
- OpenAlex
- W3113274176
- Cited by
- 17
- References
- 31
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 2
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS Spectrums (publishedVersion)
- PubMed (publishedVersion)
- Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- intravenous ketamine, treatment-resistant depression, mood disorders, transcranial magnetic stimulation, transcranial electrical stimulation, suicidal ideation, anxiety, anhedonia, depression severity
- MeSH terms
- Adult, Major Depressive Disorder, Depressive Disorder, Major, Humans, Ketamine, Middle Aged, Retrospective Studies, Anhedonia, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.